The Science of Neoplasia and Its Relationship to Aging

[1]  Dan L. Longo,et al.  Cancer Chemotherapy and Biotherapy: Principles and Practice , 2001 .

[2]  J. Shay,et al.  Telomere dynamics in cancer progression and prevention: fundamental differences in human and mouse telomere biology , 2000, Nature Medicine.

[3]  D. Green.  Apoptotic Pathways Paper Wraps Stone Blunts Scissors , 2000, Cell.

[4]  C. Buys.  Telomeres, telomerase, and cancer. , 2000, The New England journal of medicine.

[5]  D. Wynford‐Thomas.  Replicative senescence: mechanisms and implications for human cancer. , 2000, Pathologie-biologie.

[6]  D. Wink,et al.  Review article: chronic inflammation and reactive oxygen and nitrogen metabolism – implications in DNA damage and mutagenesis , 2000, Alimentary pharmacology & therapeutics.

[7]  J. Jankowski,et al.  Barrett’s Esophagus: Disregulation of Cell Cycling and Intercellular Adhesion in the Metaplasia-Dysplasia-Carcinoma Sequence , 2000, Digestion.

[8]  M. Douglas,et al.  Molecular interactions of cancer and age. , 2000, Hematology/oncology clinics of North America.

[9]  R. DuBois,et al.  The role of cyclooxygenases in inflammation, cancer, and development , 1999, Oncogene.

[10]  S. Benchimol,et al.  Alternative pathways for the extension of cellular life span: inactivation of p53/pRb and expression of telomerase , 1999, Oncogene.

[11]  E. Jaffee.  Immunotherapy of Cancer , 1999, Annals of the New York Academy of Sciences.

[12]  P. Morin,et al.  β‐catenin signaling and cancer , 1999 .

[13]  W. Blattner.  Human retroviruses: their role in cancer. , 1999, Proceedings of the Association of American Physicians.

[14]  E K Rowinsky,et al.  Ras protein farnesyltransferase: A strategic target for anticancer therapeutic development. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  L. Matrisian,et al.  Cancer biology: Extracellular proteinases in malignancy , 1999, Current Biology.

[16]  V. Steele,et al.  Progress in Cancer Chemoprevention , 1999, Annals of the New York Academy of Sciences.

[17]  S. Hursting,et al.  The anti-carcinogenic effects of dietary restriction: mechanisms and future directions. , 1999, Mutation research.

[18]  A. Bateman,et al.  Human leukocyte antigens and cancer: is it in our genes? , 1999, The Journal of pathology.

[19]  J. Robert.  Multidrug resistance in oncology: diagnostic and therapeutic approaches , 1999, European journal of clinical investigation.

[20]  Paul Polakis,et al.  The oncogenic activation of β-catenin , 1999 .

[21]  S. Lippman,et al.  Cancer chemoprevention. Part 2: Hormones, nonclassic antioxidant natural agents, NSAIDs, and other agents. , 1998, Oncology.

[22]  S. Lippman,et al.  Cancer chemoprevention. Part 1: Retinoids and carotenoids and other classic antioxidants. , 1998, Oncology.

[23]  Channing J Der,et al.  Increasing complexity of Ras signaling , 1998, Oncogene.

[24]  J. Gutkind,et al.  Cell growth control by G protein-coupled receptors: from signal transduction to signal integration , 1998, Oncogene.

[25]  C. Heckman,et al.  The sevenfold way of PKC regulation. , 1998, Cellular signalling.

[26]  S. Kaye.  Multidrug resistance: clinical relevance in solid tumours and strategies for circumvention. , 1998, Current opinion in oncology.

[27]  M. Volm,et al.  Multidrug resistance and its reversal. , 1998, Anticancer research.

[28]  John Calvin Reed.  Dysregulation of apoptosis in cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  S. Yuspa.  The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis. , 1998, Journal of dermatological science.

[30]  E. Fearon.  Human cancer syndromes: clues to the origin and nature of cancer. , 1997, Science.

[31]  V. Beral,et al.  Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer , 1997, The Lancet.

[32]  R. Vestal.  Aging and pharmacology , 1997, Cancer.

[33]  D M Leonard,et al.  Ras farnesyltransferase: a new therapeutic target. , 1997, Journal of medicinal chemistry.

[34]  D. Dunnion,et al.  HLA and cancer: implications for cancer immunotherapy and vaccination. , 1997, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[35]  Wyllie Ah.  Apoptosis and carcinogenesis. , 1997 .

[36]  L. Ellis.  Cancer chemotherapy and biotherapy: Principles and practice , 1997 .

[37]  Yosef Yarden,et al.  ErbB Receptors and EGF-like Ligands: Cell Lineage Determination and Oncogenesis Through Combinatorial Signaling , 1997, Journal of Mammary Gland Biology and Neoplasia.

[38]  L. Grochow,et al.  Pharmacology of cancer chemotherapy in the older person. , 1997, Clinics in geriatric medicine.

[39]  C. Sherr.  Cancer Cell Cycles , 1996, Science.

[40]  K. Kinzler,et al.  Lessons from Hereditary Colorectal Cancer , 1996, Cell.

[41]  O. Pereira-smith,et al.  Replicative Senescence: Implications for in Vivo Aging and Tumor Suppression , 1996, Science.

[42]  A. Dipple.  DNA adducts of chemical carcinogens. , 1995, Carcinogenesis.

[43]  P. Schofield,et al.  Growth factors, cytokines and soluble forms of receptor molecules in cancer patients. , 1995, Anticancer research.

[44]  K. Kerlikowske,et al.  Hormone replacement therapy and endometrial cancer risk: a meta-analysis. , 1995, Obstetrics and gynecology.

[45]  L. Hayflick.  How and why we age , 1994, Experimental Gerontology.

[46]  S. Yuspa.  The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis--thirty-third G. H. A. Clowes Memorial Award Lecture. , 1994, Cancer research.

[47]  I. Magrath,et al.  Point mutations in the c–Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas , 1993, Nature Genetics.

[48]  J. Nevins,et al.  E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. , 1992, Science.

[49]  C. Sawyers,et al.  Dominant negative MYC blocks transformation by ABL oncogenes , 1992, Cell.

[50]  P. Meltzer,et al.  Amplification of a gene encoding a p53-associated protein in human sarcomas , 1992, Nature.

[51]  S. Shurtleff,et al.  Myc rescue of a mutant CSF-1 receptor impaired in mitogenic signalling , 1991, Nature.

[52]  B. Vogelstein,et al.  p53 mutations in human cancers. , 1991, Science.

[53]  M. Welsh,et al.  Depletion of c-myc with specific antisense sequences reverses the transformed phenotype in ras oncogene-transformed NIH 3T3 cells , 1991, Molecular and cellular biology.

[54]  Arnold J. Levine,et al.  The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 , 1990, Cell.

[55]  H. Moses,et al.  Growth factors and cancer. , 1986, Cancer research.

[56]  E. Speckmann,et al.  Diet, nutrition, and cancer. , 1976, The American journal of clinical nutrition.

[57]  C. Franceschi,et al.  The immune system in the elderly , 2004, Immunologic research.

[58]  A. de la Chapelle,et al.  Hereditary colorectal cancer. , 2003, The New England journal of medicine.

[59]  J. Campisi.  Cancer, aging and cellular senescence. , 2000, In vivo.

[60]  D. Quaglino,et al.  The immune system in the elderly: II. Specific cellular immunity. , 1999, Immunologic research.

[61]  V. Murray.  A survey of the sequence-specific interaction of damaging agents with DNA: emphasis on antitumor agents. , 1999, Progress in nucleic acid research and molecular biology.

[62]  I. Hickson,et al.  Genetic disorders associated with cancer predisposition and genomic instability. , 1999, Progress in nucleic acid research and molecular biology.

[63]  W. Stetler-Stevenson,et al.  Matrix metalloproteinases and metastasis , 1999, Cancer Chemotherapy and Pharmacology.

[64]  N. Ahn,et al.  Signal transduction through MAP kinase cascades. , 1998, Advances in cancer research.

[65]  J. Campisi.  Aging and cancer: the double-edged sword of replicative senescence. , 1997, Journal of the American Geriatrics Society.

[66]  Harley Cb,et al.  Telomerase, checkpoints and cancer. , 1997 .

[67]  M. Schwab,et al.  Oncogene amplification in tumor cells. , 1986, Advances in cancer research.